◆英語タイトル:Aesica Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:DATA904C2737
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Aesica Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Aesica Pharmaceuticals Ltd (Aesica), a subsidiary of Consort Medical plc is a contract development and manufacturing organization (CDMO). The company offers active pharmaceutical ingredient (API) and finished dose development and manufacturing services to various pharmaceutical companies. Aesica’s services portfolio encompass pre-formulation, formulation, development and manufacturing services, analysis and stability testing, manufacture of clinical trial materials, clinical trial supply, packaging and labelling of dosage forms, regulatory support and technology transfer, among others. The company has manufacturing facilities in the UK, Germany and Italy; and an international office in Shanghai, China. Aesica is headquartered in Hertfordshire, the UK.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Aesica Pharmaceuticals Ltd – Key Facts 5
Aesica Pharmaceuticals Ltd – Key Employees 6
Aesica Pharmaceuticals Ltd – Major Products and Services 7
Aesica Pharmaceuticals Ltd – History 8
Aesica Pharmaceuticals Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Aesica Pharmaceuticals Ltd – Business Description 12
Aesica Pharmaceuticals Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Aesica Pharmaceuticals Ltd – Strengths 13
Aesica Pharmaceuticals Ltd – Weaknesses 14
Aesica Pharmaceuticals Ltd – Opportunities 15
Aesica Pharmaceuticals Ltd – Threats 16
Aesica Pharmaceuticals Ltd – Key Competitors 17
Section 3 – Company’s Lifesciences Financial Deals and Alliances 18
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19
Aesica Pharmaceuticals Ltd, Recent Deals Summary 20
Section 4 – Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
Aesica Pharmaceuticals Ltd, Key Facts 5
Aesica Pharmaceuticals Ltd, Key Employees 6
Aesica Pharmaceuticals Ltd, Major Products and Services 7
Aesica Pharmaceuticals Ltd, History 8
Aesica Pharmaceuticals Ltd, Other Locations 10
Aesica Pharmaceuticals Ltd, Subsidiaries 10
Aesica Pharmaceuticals Ltd, Key Competitors 17
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19
Aesica Pharmaceuticals Ltd, Recent Deals Summary 20
List of Figures
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18
Aesica Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 19